Previous 10 | Next 10 |
SAN FRANCISCO, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Zymergen Inc. (NASDAQ: ZY) investors with significant losses to submit your losses now . The firm is investigating possible securities law violations and certain investors may have valuable claims. Visit: ...
Gainers: Evolve Transition Infrastructure (NYSE:SNMP) +25%, Abraxas Petroleum (NASDAQ:AXAS) +15%, Standard Lithium (NYSE:SLI) +8%, SSR Mining (NASDAQ:SSRM) +6%, Fusion Fuel Green (NASDAQ:HTOO) +3%. Losers: Zymergen (NASDAQ:ZY) -76%, W&T Of...
Zymergen Inc ( NASDAQ: ZY ) opened about 70% down in the stock market on Wednesday after the company said it expects no product revenue this year and immaterial product revenue in 2022. The nosedive slashed the biofacturing firm’s market cap from over $3 billion when it went ...
Zymergen (NASDAQ: ZY) stock got slammed this morning and had plunged 76% at 11:25 a.m. EDT, thanks to some jarring updates coming in from the "biofacturing" start-up that went public just this past April via an initial public offering (IPO) , whose stock made a stellar debut ...
Boston, Massachusetts--(Newsfile Corp. - August 4, 2021) - Berman Tabacco, a national law firm representing investors, is investigating potential securities law violations against Zymergen Inc. ("Zymergen" or the "Company") (NASDAQ: ZY), a "biofacturing" company with headquarters in Emeryville...
New York, New York--(Newsfile Corp. - August 4, 2021) - Wolf Popper LLP is investigating potential securities fraud claims on behalf of purchasers of Zymergen Inc. common stock (NASDAQ: ZY). Zymergen purports to design, develop, and commercialize breakthrough products faster, cheaper, and gre...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The newly minted shares of Zymergen (NASDAQ: ZY ) are collapsing in Wednesday’s premarket trading after the biotech dumped bad news on investors. ZY stock debuted on April 21 in a Nasdaq initial public offeri...
Zymergen (NASDAQ:ZY) has lost ~76.5% in early trading after the company announced the departure of its CEO Josh Hoffman effective immediately. In addition, the issues with its commercial product pipeline led the company to expect its revenue to be “immaterial” in ...
Zymergen (NASDAQ:ZY) -74% after forecasting no revenues this year, CEO exits Flora Growth (NASDAQ:FLGC) -15%. Tellurian (NASDAQ:TELL) -12% on Q2 earnings release and to offer shares; size not determined. LivePerson (NASDAQ:LPSN) -10% on Q2 earnings release. ...
BOSTON, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Zymergen, Inc. (NASDAQ: ZY) for potential securities law violations. Investors who have lost money in their Zymergen investment should contact the firm to learn more about how they might recover those losses....
News, Short Squeeze, Breakout and More Instantly...
Ginkgo Bioworks Completes Acquisition of Zymergen PR Newswire BOSTON and EMERYVILLE, Calif. , Oct. 19, 2022 /PRNewswire/ -- Today, Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, and Zymergen (Nasdaq: ZY) announced t...